LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Net income 2016–2025
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$38.7MFY2025 · since FY2016: -$11.6M → -$38.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.7M | -422.3% |
| FY2024 | $12.0M | +112.1% |
| FY2023 | -$99.6M | +14.7% |
| FY2022 | -$116.7M | -261.4% |
| FY2021 | -$32.3M | +15.4% |
| FY2020 | -$38.2M | -9392.2% |
| FY2019 | $411,000 | -98.3% |
| FY2018 | $24.8M | +134.5% |
| FY2017 | $10.6M | +191.0% |
| FY2016 | -$11.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LFCR financial trends
LFCR RevenueLFCR Net marginLFCR Gross profitLFCR Gross marginLFCR Operating incomeLFCR Operating marginLFCR Operating cash flowLFCR Free cash flowLFCR Capital expendituresLFCR Return on equityLFCR Stock buybacksLFCR Dividends paidLFCR Total assetsLFCR Total liabilitiesLFCR Shareholders’ equityLFCR overview →